Arbutus Biopharma Corp
(NASDAQ:ABUS)
$2.03
0.03[1.50%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$2.03
0[0.00%]
Open2.000Close2.030
Vol / Avg.1.175M / 590.679KMkt Cap340.140M
Day Range1.990 - 2.05052 Wk Range1.865 - 3.145

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.

Arbutus Biopharma Stock (NASDAQ:ABUS), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No Data
Q

What is the most recent guidance for Arbutus Biopharma (ABUS)?

A

There have been no specific sales or earnings guidance reported for Arbutus Biopharma in recent months.

Browse guidance and forecast on all stocks.